TCM
AGN

Tekla Capital Management’s Allergan plc AGN Stock Holding History

Tekla Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-35,600
Closed -$9.68M – 163
2015
Q3 		$9.68M Buy
+35,600
New +$10.9M 0.35% 67

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Tekla Capital Management's AGN Position: Q2 2020 in Review

Tekla Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 157,981 shares — an estimated $28M sold.

Tekla Capital Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $128M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Tekla Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Tekla Capital Management sold 157,981 Allergan plc shares in Q2 2020, an estimated $28M.
  • Tekla Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Tekla Capital Management's Allergan plc position peaked at $128M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Tekla Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.